| Announce Date | 10/23/2025 |
| EPS Normalized Actual | $2.67 (Miss by $-0.01) |
| EPS GAAP Actual | $2.67 (Miss by $-0.01) |
| Revenue Actual | $2.7578B |
| Revenue Surprise | Beat by $2757.8M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 15.91 | 6.93 | 15.04741 | 16.41153 | 1 |
| Dec 2028 | 16.35 | 6.74 | 15.68777 | 16.70982 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.75 | 1.75 | 2.7578B | 1.41% | 2757.8M |
| FQ2 2025 (Jun 2025) | 2.34 | 2.34 | 2.8021B | 0.03% | 2802.1M |
| FQ1 2025 (Mar 2025) | 1.16 | 1.16 | 2.5258B | -6.08% | 2525.8M |
| FQ4 2024 (Dec 2024) | 1.48 | 1.48 | 2.6372B | 0.94% | 2637.2M |
| FQ3 2024 (Sep 2024) | 2.57 | 2.57 | 2.719B | -8.51% | 2719M |
| FQ2 2024 (Jun 2024) | 2.47 | 2.47 | 2.8013B | -0.18% | 2801.3M |
| FQ1 2024 (Mar 2024) | 1.65 | 1.65 | 2.6794B | 100% | 2679.4M |
| FQ4 2023 (Dec 2023) | 2.19 | 2.19 | 2.61228B | -1.47% | 2612.28M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 2.6056 | -- | 2.50388 | 2.68782 | 6 |
| FQ3 2028 (Sep 2028) | 4.0039 | -- | 3.8476 | 4.13024 | 4 |
| FQ2 2028 (Jun 2028) | 4.1354 | -- | 3.97396 | 4.26589 | 4 |
| FQ1 2028 (Mar 2028) | 2.554 | -- | 2.4543 | 2.63459 | 6 |
| FQ4 2027 (Dec 2027) | 2.71937 | -- | 2.61791 | 2.82632 | 4 |
| FQ3 2027 (Sep 2027) | 3.45407 | -- | 3.3252 | 3.58992 | 3 |
| FQ2 2027 (Jun 2027) | 3.47708 | -- | 3.34735 | 3.61384 | 7 |
| FQ1 2027 (Mar 2027) | 2.45 | -- | 2.28845 | 2.61666 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 3.09B | -- | 3B | 3.16B | 2 |
| FQ3 2028 (Sep 2028) | 3.06B | -- | 2.97B | 3.14B | 2 |
| FQ2 2028 (Jun 2028) | 3.04B | -- | 2.95B | 3.11B | 2 |
| FQ1 2028 (Mar 2028) | 3.01B | -- | 2.92B | 3.08B | 3 |
| FQ4 2027 (Dec 2027) | 2.72B | -- | 2.65B | 2.81B | 4 |
| FQ3 2027 (Sep 2027) | 2.83B | -- | 2.75B | 2.92B | 5 |
| FQ2 2027 (Jun 2027) | 2.92B | -- | 2.83B | 3.01B | 6 |
| FQ1 2027 (Mar 2027) | 2.67B | -- | 2.54B | 2.81B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.75 | 1.75 | 100% | |
| FQ2 2025 (Jun 2025) | 2.34 | 2.34 | 100% | |
| FQ1 2025 (Mar 2025) | 1.16 | 1.16 | 100% | |
| FQ4 2024 (Dec 2024) | 1.48 | 1.48 | 100% | |
| FQ3 2024 (Sep 2024) | 2.57 | 2.57 | 100% | |
| FQ2 2024 (Jun 2024) | 2.47 | 2.47 | 100% | |
| FQ1 2024 (Mar 2024) | 1.65 | 1.65 | 100% | |
| FQ4 2023 (Dec 2023) | 2.19 | 2.19 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $2.76B | $2757.8M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $2.8B | $2802.1M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $2.53B | $2525.8M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.64B | $2637.2M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.72B | $2719M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.8B | $2801.3M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.68B | $2679.4M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.61B | $2612.28M | 100% |